Quarterly report pursuant to Section 13 or 15(d)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)

v3.22.2.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Oct. 31, 2022
Oct. 31, 2021
Oct. 31, 2022
Oct. 31, 2021
Apr. 30, 2022
Intangible assets $ 3,549,427   $ 3,549,427   $ 3,549,427
Goodwill and Intangible Asset Impairment     0 $ 0  
Research and Development Expense 177,996 $ 135,220 337,269 278,833  
Uninsured cash balances 1,060,000 $ 86,658,000 1,060,000 $ 86,658,000  
Cell In A Box [Member]          
Intangible assets 1,549,427   1,549,427    
Diabetes License [Member]          
Intangible assets $ 2,000,000   $ 2,000,000    
SG Austria [Member]          
Percentage investment in SG Austria 14.30%   14.30%